Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Copper usnate is the copper (II) salt of usnic acid, a polycyclic compound naturally derived from various lichen species. It functions primarily as an antimicrobial and preservative agent. In the cosmetic and dermatological industries, it is utilized for its potent activity against Gram-positive bacteria, particularly *Cutibacterium acnes* (formerly *Propionibacterium acnes*), which is a key factor in the development of inflammatory acne. Due to its antimicrobial properties, it is incorporated into topical formulations to slow the growth of microorganisms and counteract microbial development on the skin. While it is widely used as a cosmetic ingredient, its specific antibacterial profile has led to its suggestion as a candidate for topical anti-acne therapeutic agents.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on copper usnate.